Board of Directors.


Ulrich Broeckel, MD, has over 20 years of experience in genetics and genomics and more than 10 years of experience in clinical diagnostics. He is an expert in translational pharmacogenomic research, and is a member of CPIC and the NIH initiatives on clinical pharmacogenomics. Dr. Broeckel serves as Professor of Pediatrics, Section Chief of Genomic Pediatrics, and Director of the Individualized Medicine Institute at the Medical College of Wisconsin.

carter cliff - founder

Carter Cliff is an entrepreneur with 15 years of experience in biotech, recently focused on induced-pluripotent stem cell (iPSC)-based regenerative medicine. He is a founder of Opsis Therapeutics, Dianomi Therapeutics, and Vascugen where he currently serves at CEO. Previously he held various positions at leading platform technology companies including Cellular Dynamics (acquired by FUJIFILM), Meso Scale Diagnostics (privately held), Life Technologies (acquired by Thermo Fisher Scientific), and Ingenuity Systems (acquired by Qiagen).

Susan Slocum, MBA

Susan Slocum has over 30 years experience in investment management with more than 25 years in health care investment management. She currently serves as Treasurer & Investment Officer for Children's Hospitals and Clinics of Minnesota, one of the 10 largest pediatric systems in the United States. There she chairs a number of governing committees on pensions and investments and is responsible for all banking, debt, pension and investment management functions for the pediatric health system with $900M in annual revenues and $1.3 billion in invested assets.